Table S2 from MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer
Authors:
- Celina García-GarcíaCGCelina García-García
- Martín A. RivasMRMartín A. Rivas
- Yasir H. IbrahimYIYasir H. Ibrahim
- María Teresa CalvoMCMaría Teresa Calvo
- Albert Gris-OliverAGAlbert Gris-Oliver
- Olga RodríguezOROlga Rodríguez
- Judit GruesoJGJudit Grueso
- Pilar AntónPAPilar Antón
- Marta GuzmánMGMarta Guzmán
- Claudia AuraCAClaudia Aura
- Paolo NuciforoPNPaolo Nuciforo
- Katti JessenKJKatti Jessen
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)